Memantine Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia-Reference-Cited by-同舟云学术

Memantine Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia

Published:2013-06 Issue:3 Volume:33 Page:336-342
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Rezaei Farzin,Mohammad-karimi Maryam,Seddighi Sahar,Modabbernia Amirhossein,Ashrafi Mandana,Salehi Bahman,Hammidi Siran,Motasami Hamid,Hajiaghaee Reza,Tabrizi Mina,Akhondzadeh Shahin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference47 articles.

1. Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course.;Fenton;Arch Gen Psychiatry,1991

2. The NIMH-MATRICS consensus statement on negative symptoms.;Kirkpatrick;Schizophr Bull,2006

3. Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review.;Murphy;Schizophr Res,2006

4. Food and Drug Administration perspective on negative symptoms in schizophrenia as a target for a drug treatment claim.;Laughren;Schizophr Bull,2006

5. Persistent negative symptoms in schizophrenia: an overview.;Buchanan;Schizophr Bull,2007

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive evaluation of 45 augmentation drugs for schizophrenia: a network meta-analysis;eClinicalMedicine;2024-03

2. Novel pharmacotherapy targeting the positive symptoms of schizophrenia;Expert Opinion on Pharmacotherapy;2023-07-10

3. Augmentation Therapies as Treatments for Coexisting Somatic Problems in Schizophrenia—A Systematic Review;Journal of Clinical Medicine;2023-06-12

4. Glutamatergic dysfunction in Schizophrenia;Translational Psychiatry;2022-12-03

5. Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation;Molecular Psychiatry;2022-10-24